Testicular Cancer: A Reflection on 50 Years of Discovery

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

(2013) P M Willemse et al.   BRITISH JOURNAL OF CANCER

Solid Tumors After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study

(2013) Chunkit Fung et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

(2012) Costantine Albany et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase III Study Comparing Paclitaxel–Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983

(2012) Ronald de Wit et al.   JOURNAL OF CLINICAL ONCOLOGY

Sequelae of Treatment in Long-term Survivors of Testis Cancer

(2011) Robert Abouassaly et al.   EUROPEAN UROLOGY

Association of Diagnostic Radiation Exposure and Second Abdominal-Pelvic Malignancies After Testicular Cancer

(2011) Carl van Walraven et al.   JOURNAL OF CLINICAL ONCOLOGY

Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database

(2011) Anja Lorch et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)

(2011) R. Timothy D. Oliver et al.   JOURNAL OF CLINICAL ONCOLOGY

Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) H.- J. Schmoll et al.   ANNALS OF ONCOLOGY

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

(2010) Darren R. Feldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Testis Cancer Survivors' Health Behaviors: Comparison With Age-Matched Relative and Demographically Matched Population Controls

(2010) Eileen H. Shinn et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

(2010) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Testicular Cancer Survivorship: Research Strategies and Recommendations

(2010) L. B. Travis et al.   JNCI-Journal of the National Cancer Institute

Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?

(2009) Yaron Ehrlich et al.   JOURNAL OF CLINICAL ONCOLOGY

High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy

(2009) Dirk H. Westermann et al.   WORLD JOURNAL OF UROLOGY

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

(2008) Peter Albers et al.   JOURNAL OF CLINICAL ONCOLOGY